HemaSphere (Aug 2023)

P861: PERSISTENT BONE MARROW AND IMAGING MRD NEGATIVITY AS CRITERIA TO STOP LENALIDOMIDE MAINTENANCE FOLLOWING ASCT: PRELIMINARY RESULTS OF A SINGLE-CENTER PROSPECTIVE COHORT STUDY

  • Panagiotis Malandrakis,
  • Ioannis Ntanasis-Stathopoulos,
  • Ioannis Kostopoulos,
  • Maria Gavriatopoulou,
  • Foteini Theodorakakou,
  • Despina Fotiou,
  • Magdalini Migkou,
  • Maria Roussou,
  • Vassiliki Spiliopoulou,
  • Evangelos Eleutherakis-Papaiakovou,
  • Efstathios Kastritis,
  • Ourania Tsitsiloni,
  • Meletios A. Dimopoulos,
  • Evangelos Terpos

DOI
https://doi.org/10.1097/01.HS9.0000970348.49945.47
Journal volume & issue
Vol. 7
p. e4994547

Abstract

Read online

No abstracts available.